Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
Laura E. Benjamin, Dragan Golijanin, Ahuva Itin et al. · Journal of Clinical Investigation · 1999
Features that distinguish tumor vasculatures from normal blood vessels are sought to enable the destruction of preformed tumor vessels. We show that blood vessels in both a xenografted tumor and primary human tumors contain a sizable fraction of immature blood vessels that have not yet recruited periendothelial cells. These immature vessels are selectively obliterated as a consequence of vascular endothelial growth factor (VEGF) withdrawal. In a xenografted glioma, the selective vulnerability of immature vessels to VEGF loss was demonstrated by downregulating VEGF transgene expression using a tetracycline-regulated expression system. In human prostate cancer, the constitutive production of VEGF by the glandular epithelium was suppressed as a consequence of androgen-ablation therapy. VEGF loss led, in turn, to selective apoptosis of endothelial cells in vessels devoid of periendothelial cells. These results suggest that the unique dependence on VEGF of blood vessels lacking periendothelial cells can be exploited to reduce an existing tumor vasculature.
Cited by 1,241 works. doi:10.1172/jci5028 Open-access PDF
Authors
References
- Cancer: Principles and Practice of Oncology.
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
- Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
- Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
- Requirement of Vascular Integrin α v β 3 for Angiogenesis
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
- Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance